Skinvisible, Inc. is pharmaceutical research company, which through its subsidiary engages in the development of polymer delivery system, Invisicare and formulated over forty topical skin products. It operates under the trademarks Skinvisible, Invisicare, JUSTCARE, Work Gluv, Bare Sunless Tanning, Kintari and Skinbrella. The company was founded by Terry H. Howlett on March 5, 1998 and is headquartered in Las Vegas, NV.
Company profile
Ticker
SKVI
Exchange
Website
CEO
Terry H. Howlett
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
SKINVISIBLE INC
SEC CIK
Corporate docs
IRS number
880344219
SKVI stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
16 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
8-K
Changes in Registrant's Certifying Accountant
25 Oct 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 731.00 | 731.00 | 731.00 | 731.00 | 731.00 | 731.00 |
Cash burn (monthly) | 939.00 | 10.56 k | 37.70 k | 39.30 k | 1.61 k | 9.90 k |
Cash used (since last report) | 6.73 k | 75.72 k | 270.42 k | 281.84 k | 11.52 k | 71.02 k |
Cash remaining | -6.00 k | -74.99 k | -269.69 k | -281.11 k | -10.79 k | -70.29 k |
Runway (months of cash) | -6.4 | -7.1 | -7.2 | -7.2 | -6.7 | -7.1 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 23 | Mcmorran Doreen | Debt Conversion Rights (Warrant) Common Stock | Conversion | Acquire C | No | No | 0.15 | 12,562,975 | 1.88 mm | 37,724,925 |
31 Jan 23 | Mcmorran Doreen | Debt Conversion Rights Common Stock | Conversion | Acquire C | No | No | 0.1 | 25,125,950 | 2.51 mm | 25,161,950 |
31 Jan 23 | Howlett Terry | Debt Conversion Rights (Warrant) Common Stock | Conversion | Acquire C | No | No | 0.15 | 14,299,035 | 2.14 mm | 43,051,571 |
31 Jan 23 | Howlett Terry | Debt Conversion Rights Common Stock | Conversion | Acquire C | No | No | 0.1 | 28,598,070 | 2.86 mm | 28,752,536 |
31 Jan 23 | Mcmorran Doreen | Debt Conversion Rights (Warrant) Common Stock | Conversion | Acquire C | No | No | 0.15 | 12,562,975 | 1.88 mm | 37,724,925 |
31 Jan 23 | Mcmorran Doreen | Debt Conversion Rights Common Stock | Conversion | Acquire C | No | No | 0.1 | 25,125,950 | 2.51 mm | 25,161,950 |